Sponsored

The private equity industry must take ownership of its diversity challenge if it wants to become more inclusive and relatable, say Investec’s Nicole Goodwin and Rebecca Moss.

Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.

The pandemic has heightened demand for some healthcare sectors while exposing fragility in others, says 3i director Severin Matten.

The secondaries market will continue on its growth trajectory and play an increasingly important role despite the threat of a market correction, says global co-head of private capital advisory at Jefferies, Scott Beckelman.

David Markson, a managing director with Evercore’s private capital advisory, explores the dynamics driving the strong LP secondaries market and how long they are likely to remain in play.

It is important to be able to flex between traditional LP secondaries and GP-leds, say Fort Washington Capital Partners managing directors Rob Maeder and Steve Baker.

With so many GP-led deals coming to market, activity drivers vary in key markets, but demand is struggling to keep up, say LGT Capital Partners’ partner and co-head of secondaries André Aubert and partners Andrew DiGeronimo and Brooke Zhou.

What seems like a bold prediction at first, may well be a conservative estimate, writes Whitehorse Liquidity Partners managing partner Yann Robard.

While significant capital has been raised to pursue the flourishing GP-led secondaries opportunity, supply/demand fundamentals remain highly attractive, says Barry Miller, partner in the secondary solutions group at Ares Management.

Interest in GP-led transactions is surging, but investors should maintain a holistic view of the secondaries market, say Sixpoint Partners’ Shawn Schestag and Andrew Gulotta, partners in the firm’s secondaries advisory business.